catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Procedurecatheter-based ablation of atrial fibrillation (pulmonary vein isolation)
NCT Number: NCT03718364
Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).
Interested in participating?
Request Info18 year and older
All sexes
Observational
Cardiology/Electrophysiology, University Hospital Basel, Basel, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Time frame: before catheter-based ablation of atrial fibrillation and 3, 6 and 12 months after catheter-based ablation of atrial fibrillation
changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Time frame: before catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
echocardiography of left cardiac atrium
Time frame: 12 months after catheter-based ablation of atrial fibrillation and then at intervals of one year until 2035
changes in retention rate of normal sinus rhythm after catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Time frame: Blood samples gained during catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Blood samples (biobanking) for determination of factors associated with long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation). Decisions about future analyses to be performed from stored samples will be based exclusively on scientific reasons.
Contact information is provided by the study sponsor or research team.
Gian Voellmin, MSc
CONTACT
Michael Kuehne, MD
CONTACT
University Hospital, Basel, Switzerland
Other
Acronym: SWISS-AF-PVI)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07081711
Aortic Diseases, Arrhythmias, Cardiac
Cleveland, Ohio, United States
View Trial DetailsNCT07227532
Arrhythmias, Cardiac, Atrial Fibrillation
Phoenix, Arizona, United States
View Trial DetailsNCT07298473
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, Alabama, United States
View Trial DetailsNCT07217067
Arrhythmias, Cardiac, Atrial Fibrillation
Tupelo, Mississippi, United States
View Trial Details